Kari Grønås Dyvik
Keine laufenden Positionen mehr
Profil
Kari Grønås Dyvik formerly worked at Lytix Biopharma AS, as Director, Photocure ASA, as Manager-Pharmaceutical Development, Nycomed ASA, as Principal, GE Healthcare Ltd.
(United Kingdom), as Principal, and Algeta ASA, as Senior Vice President-Operations from 2011 to 2013.
Ms. Dyvik received her graduate degree in 1989 from the University of Oslo.
Ehemalige bekannte Positionen von Kari Grønås Dyvik
| Unternehmen | Position | Ende |
|---|---|---|
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Corporate Officer/Principal | - |
| Nycomed ASA | Corporate Officer/Principal | - |
| PHOTOCURE ASA | Corporate Officer/Principal | - |
| LYTIX BIOPHARMA | Direktor/Vorstandsmitglied | - |
| ALGETA ASA | Geschäftsführer | - |
Ausbildung von Kari Grønås Dyvik
| University of Oslo | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
| Nycomed ASA | Health Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
